MARY PREVOST: Open Payments
NPI 1306975974 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,285 in 126 payments from 17 companies in 2025. Trend: 2023 $3,367 · 2024 $2,702 · 2025 $2,285
Food & beverage: $2,285
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 29 | $353 |
| ABBVIE INC. | 17 | $339 |
| UCB, Inc. | 19 | $330 |
| Mallinckrodt Hospital Products Inc. | 15 | $305 |
| Novartis Pharmaceuticals Corporation | 11 | $237 |
| Novo Nordisk Inc | 7 | $192 |
| Janssen Biotech, Inc. | 8 | $184 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $101 |
| GlaxoSmithKline, LLC. | 5 | $76 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
Products named: Bimzelx, ACTHAR, COSENTYX, TREMFYA, ENBREL, Ozempic, RINVOQ, OTEZLA.
Industry payments across NC — which companies pay providers there.
